Point72 Hong Kong’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-571
Closed -$23.1K 438
2025
Q1
$23.1K Buy
+571
New +$23.1K ﹤0.01% 383
2022
Q3
Sell
-398
Closed -$4K 1364
2022
Q2
$4K Sell
398
-1,844
-82% -$18.5K ﹤0.01% 1290
2022
Q1
$32K Buy
+2,242
New +$32K ﹤0.01% 954
2021
Q4
Sell
-650
Closed -$15K 1302
2021
Q3
$15K Sell
650
-2,073
-76% -$47.8K ﹤0.01% 1135
2021
Q2
$68K Buy
2,723
+2,464
+951% +$61.5K ﹤0.01% 844
2021
Q1
$8K Sell
259
-336
-56% -$10.4K ﹤0.01% 1089
2020
Q4
$15K Buy
595
+29
+5% +$731 ﹤0.01% 1008
2020
Q3
$17K Buy
566
+202
+55% +$6.07K ﹤0.01% 896
2020
Q2
$9K Buy
364
+334
+1,113% +$8.26K ﹤0.01% 985
2020
Q1
$1K Sell
30
-302
-91% -$10.1K ﹤0.01% 863
2019
Q4
$7K Buy
+332
New +$7K ﹤0.01% 1003
2019
Q3
Sell
-4,008
Closed -$77K 966
2019
Q2
$77K Buy
+4,008
New +$77K 0.02% 544